U.S. Physical Therapy, Inc.
USPH
$80.84
-$2.14-2.58%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 553.64M | 535.31M | 523.60M | 512.76M | 508.38M |
| Total Other Revenue | 110.79M | 103.76M | 97.63M | 92.92M | 90.25M |
| Total Revenue | 664.43M | 639.06M | 621.23M | 605.68M | 598.63M |
| Cost of Revenue | 518.98M | 498.75M | 485.52M | 471.63M | 462.12M |
| Gross Profit | 145.45M | 140.32M | 135.71M | 134.06M | 136.51M |
| SG&A Expenses | 58.29M | 56.62M | 54.28M | 52.18M | 51.95M |
| Depreciation & Amortization | 17.85M | 14.96M | 14.96M | 14.96M | 14.96M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 595.12M | 570.33M | 554.76M | 538.76M | 529.03M |
| Operating Income | 69.31M | 68.74M | 66.47M | 66.92M | 69.60M |
| Income Before Tax | 60.21M | 41.99M | 45.44M | 49.74M | 49.38M |
| Income Tax Expenses | 14.61M | 10.18M | 11.18M | 12.33M | 12.16M |
| Earnings from Continuing Operations | 45.60 | 31.81 | 34.26 | 37.41 | 37.22 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -14.18M | -8.98M | -8.80M | -8.54M | -8.98M |
| Net Income | 31.42M | 22.84M | 25.46M | 28.88M | 28.24M |
| EBIT | 69.31M | 68.74M | 66.47M | 66.92M | 69.60M |
| EBITDA | 87.99M | 85.85M | 83.16M | 82.92M | 85.29M |
| EPS Basic | 1.84 | 0.93 | 1.06 | 1.23 | 1.34 |
| Normalized Basic EPS | 1.82 | 2.31 | 2.24 | 2.29 | 2.33 |
| EPS Diluted | 1.84 | 0.93 | 1.06 | 1.23 | 1.34 |
| Normalized Diluted EPS | 1.82 | 2.31 | 2.24 | 2.29 | 2.33 |
| Average Basic Shares Outstanding | 60.26M | 60.15M | 60.06M | 58.71M | 56.72M |
| Average Diluted Shares Outstanding | 60.26M | 60.15M | 60.06M | 58.71M | 56.72M |
| Dividend Per Share | 1.76 | 1.75 | 1.74 | 1.73 | 1.72 |
| Payout Ratio | 84.46% | 115.36% | 102.72% | 83.56% | 85.44% |
